We have previously reported that HGF induces resistance to erlotinib and gefitinib in EGFR‐mutated NSCLC cell lines HCC827and PC‐9 and that stromal fibroblasts are the major source of HGF production.14 Here, HGF is linked to non-small cell lung carcinoma.